ICD-10 code M94.1: Relapsing polychondritis coding guide

Key Takeaways

ICD-10 code M94.1 is the billable, specific code for relapsing polychondritis, a rare systemic autoimmune disease that causes recurrent cartilage inflammation.

M94.1 is valid for FY2026 HIPAA-covered transactions, effective October 1, 2025, under parent category M94 (Other disorders of cartilage) in the M00-M99 musculoskeletal chapter.

Panchondritis is an older clinical name for the same condition, not an official ICD-10-CM inclusion term; M94.1 carries no inclusion terms or Excludes notes, and no further code subdivision exists.

Practice management software like Pabau validates insurer-submission fields and tracks claim status on rare-disease claims, while its clinical documentation keeps the record organized for coders assigning codes like M94.1.

ICD-10 code M94.1 is the billable diagnosis code for relapsing polychondritis, a rare autoimmune disease that inflames cartilage throughout the body until it’s destroyed. Most coders will see it only a handful of times in a career, and that rarity is exactly the problem. The documentation touches several organ systems at once, so one missed detail on an already unusual claim stalls it in review.

Get it wrong, and that claim sits in limbo right when a practice can least afford it. The sections below sort out what makes M94.1 stick to a claim, and what tends to send it back.

Is ICD-10 code M94.1 billable? Quick reference

ICD-10 code M94.1 is billable and specific in ICD-10-CM. Coders can use it directly on HIPAA-covered claims without needing a more specific code. The FY2026 edition took effect October 1, 2025, and stays valid through September 30, 2026.

Because M94.1 is a leaf node with no child codes, coders assign it directly to any encounter where a physician has documented relapsing polychondritis or panchondritis. No additional specificity code is needed to make the claim billable. For accurate claims management workflows, verify the FY year on submission, since ICD-10-CM codes reset annually on October 1.

What is relapsing polychondritis? A clinical overview for coders

Relapsing polychondritis is a rare systemic autoimmune disease. The immune system attacks cartilaginous tissue throughout the body, causing recurring episodes of inflammation followed by progressive structural destruction. Cartilage lacks blood vessels, so once it is destroyed, it does not regenerate.

This matters for coding because the clinical picture spans multiple organ systems. A single encounter may generate documentation for ear involvement, joint pain, respiratory compromise, and ocular inflammation at the same time. Coders who also handle other low-frequency diagnoses, like H54.3, run into the same challenge. They have to figure out which manifestation one code already covers, and which needs a code of its own.

Which cartilage sites does it affect most often?

• Auricular cartilage: inflammation of the ear pinna (sparing the non-cartilaginous earlobe) is the classic presenting sign
• Nasal cartilage: saddle-nose deformity can develop after recurrent episodes
• Laryngeal and tracheal cartilage: may cause hoarseness, stridor, or respiratory compromise
• Costal cartilage: chest wall pain and tenderness on palpation
• Articular cartilage: seronegative inflammatory arthritis affecting peripheral and axial joints
• Ocular structures: episcleritis, scleritis, and uveitis occur because the sclera and cornea are proteoglycan-rich connective tissues targeted by the same autoimmune process that attacks cartilage

Panchondritis is the older name clinicians used for this multi-site presentation. It still turns up in some literature and in the WHO ICD-10 browser, the separate international classification WHO maintains. It is not listed as an inclusion term in the US ICD-10-CM tabular list that coders actually bill from.

Where M94.1 sits in the ICD-10-CM hierarchy

Knowing where ICD-10 code M94.1 sits in the classification tree helps coders navigate related codes and sidestep hierarchy errors. The code descends through four levels, from chapter down to leaf node.

The parent category M94 groups several distinct cartilage disorders together. M94.1 sits alongside codes for chondromalacia (M94.2x), other specified disorders (M94.8x), and unspecified (M94.9) cartilage disorders. Elsewhere in the same musculoskeletal chapter, coders handle plenty of similarly specific codes, such as M41.9, that follow the same broad-category-to-billable-subcode pattern. The CMS ICD-10 codes page publishes the authoritative annual tabular list confirming this hierarchy for each fiscal year.

Does ICD-10 code M94.1 have inclusion or exclusion notes?

ICD-10 code M94.1 carries no ICD-10-CM inclusion terms, Excludes1, or Excludes2 notes in the official tabular list. Knowing that, plus the older clinical name still seen in some documentation, helps coders avoid unnecessary provider queries on rare-disease claims.

Alternate clinical name

• Panchondritis – an older clinical term describing diffuse inflammation of cartilage throughout the body. It is not an ICD-10-CM inclusion term or index entry; the Alphabetic Index maps this condition to M94.1 under “Polychondritis (atrophic)(chronic) – relapsing.” When a physician documents either name in the record, assign M94.1 directly.

What’s excluded from M94.1, and what isn’t

M94.1 does not carry Excludes1 or Excludes2 notes in the ICD-10-CM tabular list, so no conditions are formally excluded from it. Even so, a few things trip coders up when reviewing associated documentation:

• Systemic manifestations: if the encounter documents specific organ complications (such as aortitis, tracheobronchial collapse, or glomerulonephritis) caused by relapsing polychondritis, those manifestations are coded separately in addition to M94.1
• Arthropathy: inflammatory joint involvement in relapsing polychondritis is typically captured by M94.1 itself, not an additional arthropathy code, unless the physician specifies a separately diagnosed joint condition
• Do not confuse with: M94.0 (Chondrocostal junction syndrome, also called Tietze’s disease), M94.2x (Chondromalacia), or M11.x (Crystal arthropathies) – these require distinct clinical documentation and different diagnoses

Structured clinical records separate the primary diagnosis from associated manifestations. That cuts down on query time and supports cleaner claim submission for complex autoimmune cases like this one.

Which codes commonly appear alongside M94.1?

Relapsing polychondritis rarely shows up as an isolated finding on a claim. These are the codes most likely to appear alongside M94.1, organized by clinical context.

For practices managing complex autoimmune patients, structured patient care management workflows help ensure secondary codes get captured at every encounter instead of surfacing during an audit. The AAPC ICD-10-CM lookup is a useful tool for verifying adjacent codes in the M94 block before submission.

What clinical signs support an M94.1 diagnosis?

M94.1 can only be assigned once a physician has documented the diagnosis of relapsing polychondritis or panchondritis. Coders do not assign this code from symptoms alone. These are the clinical findings that typically support the diagnosis and should appear in the medical record before the code is used.

What to look for in the chart

• Bilateral auricular chondritis with erythema, tenderness, and swelling of the ear pinna (sparing the earlobe)
• Nasal chondritis or confirmed saddle-nose deformity
• Inflammatory arthropathy that is seronegative (negative rheumatoid factor)
• Ocular inflammation (episcleritis, scleritis, or uveitis) documented in the encounter
• Laryngeal or tracheal chondritis with hoarseness, stridor, or airway tenderness
• Cochlear or vestibular involvement (sensorineural hearing loss, vertigo, tinnitus)
• Histological confirmation (biopsy showing cartilage inflammation with or without perichondritis) when performed

Rheumatologists often use the McAdam criteria, three or more of the features above, to confirm the diagnosis. ICD-10-CM itself sets no specific threshold for code assignment. What matters for the coder is that the physician made and documented the diagnosis. If the record lists symptoms only, without a confirmed diagnosis, query the provider before assigning M94.1. The same rule holds for other complex injury codes, such as S06.821S: do not code from symptoms when the note stops short of a diagnosis.

Coding guidelines: when to use M94.1, and when not to

Accurate assignment of the M94.1 diagnosis code depends on what the physician documents, not on what the coder observes in the clinical notes. These guidelines address the most common errors seen with rare autoimmune disease codes.

When to assign M94.1

• The physician (or other qualified provider) has explicitly documented “relapsing polychondritis” or “panchondritis” in the encounter record
• The encounter is for active disease, a monitoring visit, or a flare of a previously established diagnosis
• A rheumatology consultation confirms the diagnosis in a referral note included with the encounter documentation

When NOT to assign M94.1

• The record documents only symptoms (ear pain, joint swelling, nasal tenderness) without a confirmed diagnosis from the treating provider
• The diagnosis is listed as “possible”, “probable”, or “rule out” relapsing polychondritis – ICD-10-CM outpatient coding guidelines prohibit assigning probable diagnoses in the outpatient setting
• The condition is in complete remission and the visit is for an unrelated reason (use the personal history code Z87.39 instead)

Documenting the clinical basis clearly in the patient’s record also supports HIPAA-compliant coding. Practices that rely on HIPAA-compliant documentation workflows reduce audit exposure when rare disease codes like M94.1 attract payer attention. The CDC/NCHS ICD-10-CM web tool provides the official US tabular list and index for verifying code assignment rules year by year.

Reduce coding errors on rare disease claims

Pabau’s clinical documentation tools help practices structure encounter records so codes like M94.1 are supported by the documentation before claims go out, not discovered during audit.

Book a demo

How Pabau keeps documentation organized for accurate coding

Rare autoimmune conditions like relapsing polychondritis create a specific coding challenge. A rheumatologist may confirm the diagnosis. The supporting notes are often scattered across encounter records, referral letters, and diagnostic reports before reaching a claim. When those records live in separate systems, coders spend time chasing documentation instead of coding.

Practice management software like Pabau consolidates clinical notes, referral documents, and encounter records into a single patient record. A coder reviewing an M94.1 encounter can then pull up the confirmed diagnosis, the supporting symptom documentation, and any referral letters from one place. The digital forms feature centralizes patient-facing intake, consent, and medical history collection directly in that record. It’s available alongside the physician’s documented diagnosis by the time coding happens.

For practices managing systemic autoimmune patients across multiple specialties, compliance management workflows help teams maintain the audit trail that supports rare disease code assignment. Practices in dermatology and rheumatology settings can review how dermatology EMR software handles complex multi-system documentation. Those managing the joint and cartilage side of the disease may find similar value in physical therapy software built for musculoskeletal tracking.

Getting M94.1 right, from chart to claim

Relapsing polychondritis claims usually fail for one of two reasons. One is a coder assigning a symptom code before the diagnosis is confirmed. The other is a missed secondary manifestation code because the documentation is scattered. ICD-10 code M94.1 itself is billable and specific. What actually matters is making sure the record backs it up before the claim goes out.

Pabau keeps patient data and documentation organized in one place, so practices can pull up the confirmed diagnosis and supporting notes quickly at coding time. To see how it handles documentation for rare-disease claims, book a demo.

Continue your research

Also coding a skin or tissue graft on the same claim? 15152 walks through the billing rules for epidermal autografts, another code where documentation detail decides the outcome.

Handling DME or supply codes alongside a rare diagnosis? A4720 breaks down Medicare coverage rules for a commonly misfiled HCPCS code.

Coding an eye injury alongside a systemic condition? S05.12XD covers the documentation rules for a related ocular code.

Frequently Asked Questions